Previous 10 | Next 10 |
2024-05-05 01:21:09 ET AxoGen, Inc. (AXGN) Q1 2024 Earnings Conference Call May 02, 2024 08:00 AM ET Company Participants Harold Tamayo - VP, Finance and IR Karen Zaderej - Chairman, CEO and President Nir Naor - CFO Conference Call Participants Michae...
2024-05-02 11:57:17 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Axogen (NASDAQ: AXGN ) just reported results for the first quarter of 2024. Axogen reported earnings per share of -6 cents. This was above the analyst estimate for EPS of ...
2024-05-02 07:15:14 ET More on AxoGen AxoGen, Inc. (AXGN) Q4 2023 Earnings Call Transcript AxoGen Q1 2024 Earnings Preview AxoGen Non-GAAP EPS of -$0.06 beats by $0.02, revenue of $42.9M beats by $1.9M Seeking Alpha’s Quant Rating on AxoGen His...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
ALACHUA, Fla. and TAMPA, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the first quarter ended March 31,...
2024-05-01 14:47:21 ET More on AxoGen AxoGen, Inc. (AXGN) Q4 2023 Earnings Call Transcript AxoGen Non-GAAP EPS of -$0.06 beats by $0.02, revenue of $42.9M beats by $1.9M AxoGen Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on AxoGen His...
2024-05-01 11:22:41 ET Major earnings expected before the bell on Thursday include: ConocoPhillips ( COP ) Iron Mountain ( IRM ) Moderna ( MRNA ) Organon ( OGN ) Shell ( SHEL ) Read the full article on Seeking Alpha For further details...
ALACHUA, Fla. and TAMPA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the first surgical implantations of its newest product, Avive+ Soft Tissue MatrixȒ...
ALACHUA, Fla. and TAMPA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report first quarter 2024 financial results on Thursday, May 2, 2024...
2024-04-09 21:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
ALACHUA and TAMPA, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report second quarter 2024 financial results on Thursday, August 8, 2024, b...
2024-07-01 07:30:05 ET Raymond James analyst issues OUTPERFORM recommendation for AXGN on July 1, 2024 05:51AM ET. AXGN was trading at $7.24 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 recommendations
ALACHUA, Fla. and TAMPA, Fla., July 01, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced making an inducement grant on July 1, 2024, under NASDAQ listing rule 5635(c)(4) in conn...